Market research

ABVX Abivax SA American Depositary Shares

NASDAQ USD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts

Market cap: 10B
P/E ratio: Not available
Analyst target: 165
Dividend yield: Not available
Beta: -0.25

Loading price history…

Profile

Company facts

Exchange: NASDAQ
Currency: USD
Sector: Healthcare
Industry: Biotechnology
ISIN: US00370M1036
Market cap: 10B
P/E ratio: Not available
Analyst target: 165
Dividend yield: Not available
Beta: -0.25

About

About Abivax SA American Depositary Shares

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Visit company website

Reported results

Fundamentals

Open this section to load reported financial history.

Annual returns

No comments yet

Start a focused discussion about ABVX.

ABVX Abivax SA American Depositary Shares

Price & volume

Company facts

About Abivax SA American Depositary Shares

Fundamentals

Earnings

Cash flow

Profitability

Valuation

Performance

Annual returns

Investor discussion

No comments yet